Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 06, 2026 Filed Sep 9, 2026 22:47 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 92 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001924980-26-000004 · wk-form4_1788994034.xml · derivative · entry 7 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185 Underlying: Bio-Rad A Common Stock · 92 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:47 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 34 | $386.11 | $13,127.74 |
DisclosureSEC source: 0001924980-26-000004 · wk-form4_1788994034.xml · nonDerivative · entry 4 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,734 Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:47 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 92 | $0.00 | $0.00 |
DisclosureSEC source: 0001924980-26-000004 · wk-form4_1788994034.xml · nonDerivative · entry 3 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,768 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:46 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 1,056 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002022345-26-000004 · wk-form4_1788994011.xml · derivative · entry 7 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,112 Underlying: Bio-Rad A Common Stock · 1,056 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:46 UTC |
BARRY JAMESEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 470 | $386.11 | $181,471.70 |
DisclosureSEC source: 0002022345-26-000004 · wk-form4_1788994011.xml · nonDerivative · entry 4 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,024.682 Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:46 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 1,056 | $0.00 | $0.00 |
DisclosureSEC source: 0002022345-26-000004 · wk-form4_1788994011.xml · nonDerivative · entry 3 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,494.682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:46 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
Exercise / conversionRestricted Stock Units · Derivative | 864 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · derivative · entry 7 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,728 Underlying: Bio-Rad A Common Stock · 864 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:46 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
Tax withholdingBio-Rad A Common Stock | 277 | $386.11 | $106,952.47 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · nonDerivative · entry 4 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,603.12 Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:46 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
Exercise / conversionBio-Rad A Common Stock | 864 | $0.00 | $0.00 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · nonDerivative · entry 3 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,880.12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:45 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
Exercise / conversionRestricted Stock Units · Derivative | 1,152 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002024911-26-000006 · wk-form4_1788993956.xml · derivative · entry 7 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,304 Underlying: Bio-Rad A Common Stock · 1,152 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:45 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
Tax withholdingBio-Rad A Common Stock | 485 | $386.11 | $187,263.35 |
DisclosureSEC source: 0002024911-26-000006 · wk-form4_1788993956.xml · nonDerivative · entry 4 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,828 Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:45 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
Exercise / conversionBio-Rad A Common Stock | 1,152 | $0.00 | $0.00 |
DisclosureSEC source: 0002024911-26-000006 · wk-form4_1788993956.xml · nonDerivative · entry 3 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:45 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 768 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · derivative · entry 7 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,536 Underlying: Bio-Rad A Common Stock · 768 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:45 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
Tax withholdingBio-Rad A Common Stock | 305 | $386.11 | $117,763.55 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · nonDerivative · entry 4 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,651.777 Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:45 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · nonDerivative · entry 3 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,956.777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:42 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,536 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · derivative · entry 7 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,072 Underlying: Bio-Rad A Common Stock · 1,536 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:42 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
Tax withholdingBio-Rad A Common Stock | 782 | $386.11 | $301,938.02 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · nonDerivative · entry 4 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,150.963 Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:42 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
Exercise / conversionBio-Rad A Common Stock | 1,536 | $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · nonDerivative · entry 3 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,932.963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:42 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 3,455 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000940805-26-000004 · wk-form4_1788993728.xml · derivative · entry 17 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,912 Underlying: Bio-Rad A Common Stock · 3,455 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F7 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:42 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 1,854 | $386.11 | $715,847.94 |
DisclosureSEC source: 0000940805-26-000004 · wk-form4_1788993728.xml · nonDerivative · entry 4 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 449,019 Read SEC document |
| September 06, 2026 Filed Sep 9, 2026 22:42 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 3,455 | $0.00 | $0.00 |
DisclosureSEC source: 0000940805-26-000004 · wk-form4_1788993728.xml · nonDerivative · entry 3 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,873 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:47 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 228 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001924980-26-000004 · wk-form4_1788994034.xml · derivative · entry 6 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 686 Underlying: Bio-Rad A Common Stock · 228 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:47 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 82 | $386.11 | $31,661.02 |
DisclosureSEC source: 0001924980-26-000004 · wk-form4_1788994034.xml · nonDerivative · entry 2 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,676 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:47 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 228 | $0.00 | $0.00 |
DisclosureSEC source: 0001924980-26-000004 · wk-form4_1788994034.xml · nonDerivative · entry 1 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,758 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:46 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 1,027 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002022345-26-000004 · wk-form4_1788994011.xml · derivative · entry 6 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,083 Underlying: Bio-Rad A Common Stock · 1,027 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:46 UTC |
BARRY JAMESEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 369 | $386.11 | $142,474.59 |
DisclosureSEC source: 0002022345-26-000004 · wk-form4_1788994011.xml · nonDerivative · entry 2 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,438.682 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:46 UTC |
BARRY JAMESEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 1,027 | $0.00 | $0.00 |
DisclosureSEC source: 0002022345-26-000004 · wk-form4_1788994011.xml · nonDerivative · entry 1 BARRY JAMES · CIK 0002022345 · EVP, President, LSG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,807.682 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:46 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
Exercise / conversionRestricted Stock Units · Derivative | 1,027 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · derivative · entry 6 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,083 Underlying: Bio-Rad A Common Stock · 1,027 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:46 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
Tax withholdingBio-Rad A Common Stock | 329 | $386.11 | $127,030.19 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · nonDerivative · entry 2 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,016.12 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:46 UTC |
EVRAN SEDATEVP, Global Supply Chain
|
Exercise / conversionBio-Rad A Common Stock | 1,027 | $0.00 | $0.00 |
DisclosureSEC source: 0001993147-26-000002 · wk-form4_1788993983.xml · nonDerivative · entry 1 EVRAN SEDAT · CIK 0001993147 · EVP, Global Supply Chain 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,345.12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 51.2870 and 33.9860 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2026 and 06/30/2026, respectively. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:45 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
Exercise / conversionRestricted Stock Units · Derivative | 1,027 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002024911-26-000006 · wk-form4_1788993956.xml · derivative · entry 6 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,083 Underlying: Bio-Rad A Common Stock · 1,027 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:45 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
Tax withholdingBio-Rad A Common Stock | 369 | $386.11 | $142,474.59 |
DisclosureSEC source: 0002024911-26-000006 · wk-form4_1788993956.xml · nonDerivative · entry 2 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,161 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:45 UTC |
ENGELHARDT EVA ANETTEEVP, President, CDG
|
Exercise / conversionBio-Rad A Common Stock | 1,027 | $0.00 | $0.00 |
DisclosureSEC source: 0002024911-26-000006 · wk-form4_1788993956.xml · nonDerivative · entry 1 ENGELHARDT EVA ANETTE · CIK 0002024911 · EVP, President, CDG 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:45 UTC |
DiVincenzo Jonathan P.President & COO
|
Exercise / conversionRestricted Stock Units · Derivative | 1,712 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001453524-26-000002 · wk-form4_1788993926.xml · derivative · entry 4 DiVincenzo Jonathan P. · CIK 0001453524 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,138 Underlying: Bio-Rad A Common Stock · 1,712 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:45 UTC |
DiVincenzo Jonathan P.President & COO
|
Tax withholdingBio-Rad A Common Stock | 668 | $386.11 | $257,921.48 |
DisclosureSEC source: 0001453524-26-000002 · wk-form4_1788993926.xml · nonDerivative · entry 2 DiVincenzo Jonathan P. · CIK 0001453524 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,963 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:45 UTC |
DiVincenzo Jonathan P.President & COO
|
Exercise / conversionBio-Rad A Common Stock | 1,712 | $0.00 | $0.00 |
DisclosureSEC source: 0001453524-26-000002 · wk-form4_1788993926.xml · nonDerivative · entry 1 DiVincenzo Jonathan P. · CIK 0001453524 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,631 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:45 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 685 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · derivative · entry 6 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,055 Underlying: Bio-Rad A Common Stock · 685 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F4 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:45 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
Tax withholdingBio-Rad A Common Stock | 246 | $386.11 | $94,983.06 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · nonDerivative · entry 2 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,188.777 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:45 UTC |
ENLOE COURTNEY CEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 685 | $0.00 | $0.00 |
DisclosureSEC source: 0002019843-26-000004 · wk-form4_1788993899.xml · nonDerivative · entry 1 ENLOE COURTNEY C · CIK 0002019843 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,434.777 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:44 UTC |
Mehta RajatEVP, GBL Commercial Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 1,370 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · derivative · entry 7 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,110 Underlying: Bio-Rad A Common Stock · 1,370 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:44 UTC |
Mehta RajatEVP, GBL Commercial Operations
|
Exercise / conversionRestricted Stock Units · Derivative | 456 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · derivative · entry 6 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,371 Underlying: Bio-Rad A Common Stock · 456 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:44 UTC |
Mehta RajatEVP, GBL Commercial Operations
|
Tax withholdingBio-Rad A Common Stock | 504 | $386.11 | $194,599.44 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · nonDerivative · entry 4 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,232.052 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:44 UTC |
Mehta RajatEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 1,370 | $0.00 | $0.00 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · nonDerivative · entry 3 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,736.052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:44 UTC |
Mehta RajatEVP, GBL Commercial Operations
|
Tax withholdingBio-Rad A Common Stock | 233 | $386.11 | $89,963.63 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · nonDerivative · entry 2 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 366.052 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:44 UTC |
Mehta RajatEVP, GBL Commercial Operations
|
Exercise / conversionBio-Rad A Common Stock | 456 | $0.00 | $0.00 |
DisclosureSEC source: 0002081681-26-000002 · wk-form4_1788993866.xml · nonDerivative · entry 1 Mehta Rajat · CIK 0002081681 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 599.052 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 57.9370, 53.0810 and 32.0340 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/2025, 03/31/2026 and 06/30/2026, respectively. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:42 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,370 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · derivative · entry 6 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,110 Underlying: Bio-Rad A Common Stock · 1,370 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F5 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F5 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:42 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
Tax withholdingBio-Rad A Common Stock | 559 | $386.11 | $215,835.49 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · nonDerivative · entry 2 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,396.963 Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:42 UTC |
Lakkaraju Roop KalyanEVP, Chief Financial Officer
|
Exercise / conversionBio-Rad A Common Stock | 1,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001396867-26-000004 · wk-form4_1788993769.xml · nonDerivative · entry 1 Lakkaraju Roop Kalyan · CIK 0001396867 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,955.963 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 22.0680 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2026. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:42 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 4,109 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000940805-26-000004 · wk-form4_1788993728.xml · derivative · entry 16 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,330 Underlying: Bio-Rad A Common Stock · 4,109 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F7 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F7 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| September 05, 2026 Filed Sep 9, 2026 22:42 UTC |
SCHWARTZ NORMAN DDirector · Chairman & CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 2,876 | $386.11 | $1,110,452.36 |
DisclosureSEC source: 0000940805-26-000004 · wk-form4_1788993728.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman & CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 447,418 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.